Literature DB >> 25874613

Exercise programs for people with dementia.

Dorothy Forbes1, Scott C Forbes, Catherine M Blake, Emily J Thiessen, Sean Forbes.   

Abstract

BACKGROUND: This is an update of our previous 2013 review. Several recent trials and systematic reviews of the impact of exercise on people with dementia are reporting promising findings.
OBJECTIVES: Primary objectiveDo exercise programs for older people with dementia improve their cognition, activities of daily living (ADLs), neuropsychiatric symptoms, depression, and mortality? Secondary objectivesDo exercise programs for older people with dementia have an indirect impact on family caregivers' burden, quality of life, and mortality?Do exercise programs for older people with dementia reduce the use of healthcare services (e.g. visits to the emergency department) by participants and their family caregivers? SEARCH
METHODS: We identified trials for inclusion in the review by searching ALOIS (www.medicine.ox.ac.uk/alois), the Cochrane Dementia and Cognitive Improvement Group's Specialised Register, on 4 September 2011, on 13 August 2012, and again on 3 October 2013. SELECTION CRITERIA: In this review, we included randomized controlled trials in which older people, diagnosed with dementia, were allocated either to exercise programs or to control groups (usual care or social contact/activities) with the aim of improving cognition, ADLs, neuropsychiatric symptoms, depression, and mortality. Secondary outcomes related to the family caregiver(s) and included caregiver burden, quality of life, mortality, and use of healthcare services. DATA COLLECTION AND ANALYSIS: Independently, at least two authors assessed the retrieved articles for inclusion, assessed methodological quality, and extracted data. We analysed data for summary effects. We calculated mean differences or standardized mean difference (SMD) for continuous data, and synthesized data for each outcome using a fixed-effect model, unless there was substantial heterogeneity between studies, when we used a random-effects model. We planned to explore heterogeneity in relation to severity and type of dementia, and type, frequency, and duration of exercise program. We also evaluated adverse events. MAIN
RESULTS: Seventeen trials with 1067 participants met the inclusion criteria. However, the required data from three included trials and some of the data from a fourth trial were not published and not made available. The included trials were highly heterogeneous in terms of subtype and severity of participants' dementia, and type, duration, and frequency of exercise. Only two trials included participants living at home.Our meta-analysis revealed that there was no clear evidence of benefit from exercise on cognitive functioning. The estimated standardized mean difference between exercise and control groups was 0.43 (95% CI -0.05 to 0.92, P value 0.08; 9 studies, 409 participants). There was very substantial heterogeneity in this analysis (I² value 80%), most of which we were unable to explain, and we rated the quality of this evidence as very low. We found a benefit of exercise programs on the ability of people with dementia to perform ADLs in six trials with 289 participants. The estimated standardized mean difference between exercise and control groups was 0.68 (95% CI 0.08 to 1.27, P value 0.02). However, again we observed considerable unexplained heterogeneity (I² value 77%) in this meta-analysis, and we rated the quality of this evidence as very low. This means that there is a need for caution in interpreting these findings.In further analyses, in one trial we found that the burden experienced by informal caregivers providing care in the home may be reduced when they supervise the participation of the family member with dementia in an exercise program. The mean difference between exercise and control groups was -15.30 (95% CI -24.73 to -5.87; 1 trial, 40 participants; P value 0.001). There was no apparent risk of bias in this study. In addition, there was no clear evidence of benefit from exercise on neuropsychiatric symptoms (MD -0.60, 95% CI -4.22 to 3.02; 1 trial, 110 participants; P value .0.75), or depression (SMD 0.14, 95% CI -0.07 to 0.36; 5 trials, 341 participants; P value 0.16). We could not examine the remaining outcomes, quality of life, mortality, and healthcare costs, as either the appropriate data were not reported, or we did not retrieve trials that examined these outcomes. AUTHORS'
CONCLUSIONS: There is promising evidence that exercise programs may improve the ability to perform ADLs in people with dementia, although some caution is advised in interpreting these findings. The review revealed no evidence of benefit from exercise on cognition, neuropsychiatric symptoms, or depression. There was little or no evidence regarding the remaining outcomes of interest (i.e., mortality, caregiver burden, caregiver quality of life, caregiver mortality, and use of healthcare services).

Entities:  

Mesh:

Year:  2015        PMID: 25874613      PMCID: PMC9426996          DOI: 10.1002/14651858.CD006489.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  90 in total

Review 1.  Is physical activity a potential preventive factor for vascular dementia? A systematic review.

Authors:  Dag Aarsland; Farzaneh S Sardahaee; Sigmund Anderssen; Clive Ballard
Journal:  Aging Ment Health       Date:  2010-05       Impact factor: 3.658

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Dual-task performances can be improved in patients with dementia: a randomized controlled trial.

Authors:  Michael Schwenk; Tania Zieschang; Peter Oster; Klaus Hauer
Journal:  Neurology       Date:  2010-05-05       Impact factor: 9.910

Review 4.  Physical exercise and endothelial dysfunction.

Authors:  Gabriela Lima de Melo Ghisi; Adriana Durieux; Ricardo Pinho; Magnus Benetti
Journal:  Arq Bras Cardiol       Date:  2010-10       Impact factor: 2.000

5.  Psychological effects of exercise therapy upon institutionalized geriatric mental patients.

Authors:  R R Powell
Journal:  J Gerontol       Date:  1974-03

6.  Effect of a high-intensity functional exercise program on functional balance: preplanned subgroup analyses of a randomized controlled trial in residential care facilities.

Authors:  Håkan Littbrand; Maine Carlsson; Lillemor Lundin-Olsson; Nina Lindelöf; Lena Håglin; Yngve Gustafson; Erik Rosendahl
Journal:  J Am Geriatr Soc       Date:  2011-06-30       Impact factor: 5.562

Review 7.  The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.

Authors:  J L Cummings
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

Review 8.  A systematic review of the effects of physical activity on physical functioning, quality of life and depression in older people with dementia.

Authors:  Rachel Potter; David Ellard; Karen Rees; Margaret Thorogood
Journal:  Int J Geriatr Psychiatry       Date:  2011-01-06       Impact factor: 3.485

9.  Management of mild to moderate Alzheimer's disease and dementia.

Authors:  David B Hogan; Peter Bailey; Anne Carswell; Barry Clarke; Carole Cohen; Dorothy Forbes; Malcolm Man-Son-Hing; Krista Lanctôt; Debra Morgan; Lilian Thorpe
Journal:  Alzheimers Dement       Date:  2007-09-17       Impact factor: 21.566

Review 10.  Exercise, experience and the aging brain.

Authors:  James D Churchill; Roberto Galvez; Stanley Colcombe; Rodney A Swain; Arthur F Kramer; William T Greenough
Journal:  Neurobiol Aging       Date:  2002 Sep-Oct       Impact factor: 4.673

View more
  120 in total

Review 1.  Non-pharmacological Management of Behavioral Symptoms in Frontotemporal and Other Dementias.

Authors:  Cynthia Barton; Robin Ketelle; Jennifer Merrilees; Bruce Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

Review 2.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 3.  Approaches to Deprescribing Psychotropic Medications for Changed Behaviours in Long-Term Care Residents Living with Dementia.

Authors:  Stephanie L Harrison; Monica Cations; Tiffany Jessop; Sarah N Hilmer; Mouna Sawan; Henry Brodaty
Journal:  Drugs Aging       Date:  2019-02       Impact factor: 3.923

4.  An integrative group movement program for people with dementia and care partners together (Paired PLIÉ): initial process evaluation.

Authors:  James J Casey; Krista L Harrison; Maria I Ventura; Wolf Mehling; Deborah E Barnes
Journal:  Aging Ment Health       Date:  2019-02-12       Impact factor: 3.658

5.  Dementia: What pharmacists need to know.

Authors:  Silvia Duong; Tejal Patel; Feng Chang
Journal:  Can Pharm J (Ott)       Date:  2017-02-07

Review 6.  On the Run for Hippocampal Plasticity.

Authors:  C'iana Cooper; Hyo Youl Moon; Henriette van Praag
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

7.  Nutrition and Lifestyle Intervention on Mood and Neurological Disorders.

Authors:  Gary Null; Luanne Pennesi; Martin Feldman
Journal:  J Evid Based Complementary Altern Med       Date:  2016-03-14

Review 8.  Physical Activity in Preventing Alzheimer's Disease and Cognitive Decline: A Narrative Review.

Authors:  Stefano Brini; Hamid R Sohrabi; Jeremiah J Peiffer; Mira Karrasch; Heikki Hämäläinen; Ralph N Martins; Timothy J Fairchild
Journal:  Sports Med       Date:  2018-01       Impact factor: 11.136

9.  Characteristics Associated with Quality of Life in Long-Term Care Residents with Dementia: A Cross-Sectional Study.

Authors:  Maartje S Klapwijk; Monique A A Caljouw; Marjoleine J C Pieper; Jenny T van der Steen; Wilco P Achterberg
Journal:  Dement Geriatr Cogn Disord       Date:  2016-09-27       Impact factor: 2.959

10.  Effects of Physical Activity in Nursing Home Residents with Dementia: A Randomized Controlled Trial.

Authors:  Marinda Henskens; Ilse M Nauta; Marieke C A van Eekeren; Erik J A Scherder
Journal:  Dement Geriatr Cogn Disord       Date:  2018-08-24       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.